Cytek Biosciences to Participate in Upcoming Investor Conferences
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences:
Covered in this story
Call it yourself
No calls on $CTKB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cytek Biosciences Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.